Cyprus
·

Ministry of Health: The revised list of vulnerable groups

Hands 990865

The following categories have been selected based on the existing international literature and taking into account the epidemiological data of the disease epidemic so far. COVID-19 in the international arena and in the Republic of Cyprus.

Category A:

Patients in the following categories can work provided they are not in public places and there is no increased number of people.

  1. Age over 65 years.
  2. Pre-existing Chronic Respiratory Disease (eg chronic obstructive pulmonary disease, moderate bronchial asthma)
  3. Chronic Renal Insufficiency (creatinine clearance 15-30 ml / min).
  4. Type 1 diabetes mellitus and / or with target organ damage (chronic renal failure, cardiovascular disease, retinopathy, chronic peripheral neuropathy - unless it falls into category B).
  5. Pathogenic obesity BMI> 40.
  6. Hemoglobinopathies (thalassemia homozygotes, Sickle Cell Anemia).
  7. Chronic hepatic impairment stage Child-Pugh C.
  8. Serious genetic coagulation disorders.
  9. Neuromyopathies.
  10. Pregnant women regardless of gestational age, breastfeeding and breastfeeding.

Category B:

Patients in the following categories are considered very high risk and it is recommended to work from home.

  1. Pre-existing Chronic Respiratory Disease (eg severe bronchial asthma, patient undergoing chronic oxygen therapy or non-invasive ventilation [CPAP or BiPaP] at home, severe pulmonary hypertension (NYHA III and IV), severe pulmonary fibrosis, ).
  2. Severe Chronic Renal Failure (creatinine clearance <15 ml / min and dialysis).
  3. Cardiac arrhythmia with permanent defibrillator or heart disease with permanent defibrillator and ventricular pacemaker.
  4. Heart Failure of any etiology (Ischemic or non-ischemic) stage according to NYHA III or IV.
  5. Cardiovascular disease:
    1. Recent acute coronary syndrome or revascularization surgery: angioplasty or stent implantation in the last 12 months,
    2. Aorto-coronary bypass (CABG) bypass in the last 12 months,
    3. Recent SLE in the last 12 months or with established neurological semiology.
  6. Cardiomyopathies (History of documented myocarditis, hypertrophic, dilated, invasive (amyloidosis)).
  7. Congenital heart disease after surgical correction with significant residual damage or uncorrected congenital heart disease with significant residual damage.
  8. Active use of biological agents (eg TNF inhibitors, interleukin inhibitors) or other immunosuppressive drugs.
  9. Active chronic corticosteroids (≥ 20mg prednisone or its equivalent for ≥ 1 month).
  10. Patients with a history of solid organ or hematopoietic stem cell transplantation.
  11. Patients with solid or hematologic malignancy receiving chemotherapy or radiation or immunotherapy.
  12. Patients with HIV or patients with CD4 lymphocyte count <200 / mm3.
  13. Hereditary or acquired immunodeficiencies.